Robert Klein, the chairman of the governing board for the state’s San Francisco-based stem cell institute, will today announce new grants totaling more than $200 million to develop stem cell-based therapies. The California Institute for Regenerative Medicine was established in 2004, when voters approved Proposition 71, which provided $3 billion in funding for the emerging area of medical research.